Department of Pediatrics, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.
Department of Computer Science and Engineering, Sungkyunkwan University, Suwon, Korea.
J Korean Med Sci. 2023 Feb 13;38(6):e42. doi: 10.3346/jkms.2023.38.e42.
There are inconsistent reports regarding the association between general anesthesia and adverse neurodevelopmental and behavioral disorders in children.
This nationwide administrative cohort study included children born in Korea between 2008 and 2009, and followed until December 31, 2017. The cohort included 93,717 participants who received general anesthesia with endotracheal intubation (ETI) who were matched to unexposed subjects in a 1:1 ratio. General anesthesia was defined by National Health Insurance Service treatment codes with intratracheal anesthesia, and the index date was the first event of general anesthesia. The primary outcome was attention deficit hyperactive disorder (ADHD), which was defined as at least a principal diagnosis of 10th revision of the International Classification of Diseases code F90.X after the age of 72 months. Neurodevelopment, which was assessed using a developmental screening test (Korean-Ages and Stages Questionnaire [K-ASQ]), was a secondary outcome. The K-ASQ is performed annually from 1 to 6 years of age and consists of 5 domains. The association between general anesthesia and ADHD was estimated using a Cox hazard model, and its association with neurodevelopment was estimated using a generalized estimation equation, with control for multiple risk factors beyond 1 year after the index date.
The median age at the index date was 3.8 (95% confidence interval [CI], 1.7-5.8) years, and there were 57,625 (61.5%) men. During a mean follow-up period of 5 years, the incidence rate of ADHD was 42.6 and 27.7 per 10,000 person-years (PY) in the exposed and unexposed groups, respectively (absolute rate difference 14.9 [95% CI, 12.5-17.3] per 10,000 PY). Compared to the unexposed group, the exposed group had an increased risk of ADHD (adjusted hazard ratio, 1.41 [95% CI, 1.30-1.52]). In addition, a longer duration of anesthesia with ETI and more general anesthesia procedures with ETI were associated with greater risk of ADHD. General anesthesia with ETI was also associated with poorer results in the K-ASQ.
Administration of general anesthesia with ETI to children is associated with an increased risk of ADHD and poor results in a neurodevelopmental screening test.
全麻与儿童神经发育和行为障碍的相关性存在不一致的报道。
本全国性行政队列研究纳入了 2008 年至 2009 年期间在韩国出生的儿童,并随访至 2017 年 12 月 31 日。该队列纳入了 93717 名接受气管内插管全身麻醉(ETI)的患儿,他们按照 1:1 的比例与未暴露于全身麻醉的患儿相匹配。全身麻醉通过国家健康保险服务治疗代码下的气管内麻醉来定义,而索引日期是全身麻醉的首次发生时间。主要结局是注意缺陷多动障碍(ADHD),其定义为 72 个月后至少有第 10 次修订版国际疾病分类代码 F90.X 的主要诊断。使用发育筛查测试(韩国年龄与阶段问卷[K-ASQ])评估的神经发育是次要结局。使用 Cox 风险模型估计全身麻醉与 ADHD 的相关性,并使用广义估计方程估计其与神经发育的相关性,控制了索引日期后 1 年以上的多个危险因素。
索引日期的中位年龄为 3.8 岁(95%置信区间[CI],1.7-5.8 岁),其中 57625 名(61.5%)为男性。在平均 5 年的随访期间,暴露组和未暴露组的 ADHD 发生率分别为 42.6 和 27.7/10000 人年(PY)(绝对风险差异为 14.9 [95%CI,12.5-17.3]/10000 PY)。与未暴露组相比,暴露组患 ADHD 的风险增加(调整后的危险比,1.41 [95%CI,1.30-1.52])。此外,较长的 ETI 全身麻醉持续时间和更多的 ETI 全身麻醉程序与 ADHD 风险的增加相关。ETI 全身麻醉也与 K-ASQ 结果较差相关。
对儿童进行 ETI 全身麻醉与 ADHD 风险增加和神经发育筛查测试结果较差有关。